Possible effects of IL-6 signaling on energy intake and energy expenditure under non-obesogenic conditions
Possible effects of IL-6 signaling on energy intake and energy expenditure under non-obesogenic conditions. (a) Hypothalamic IL-6/STAT3 signaling may reduce energy intake and stimulate thermogenesis and lipolysis in adipocytes. The underlying mechanisms are still largely unexplored. (b) IL-6 is released from the skeletal muscle during exercise, which may increase lipolysis and thermogenesis in adipocytes. Tumor tissues may also secrete IL-6 into the blood stream, that can over-stimulate fat catabolism and cause excessive wasting of body fat and lead to cachexia. (c) It has been shown recently that IL-6/STAT3 signaling triggers the expression of genes required for mitochondrial biogenesis and thermogenesis in preadipocytes and adipocytes, and STAT3 is necessary for thermogenic fat development. Upstream stimulators of the locally produced IL-6 may be human milk alkylglycerols (AKGs). AKGs are metabolized by ATMs into platelet-activating factor (PAF), which is non-enzymatically converted into azelaoyl PAF (AzPAF) and stimulates IL-6 release from ATMs. AzPAF is a peroxisome proliferator-activated receptor gamma (PPARγ) ligand [21]. (d) Autocrine IL-6 signaling stimulates the transcription of mitobiogenesis and thermogenesis genes in adipocytes, especially during the early postnatal life. Upstream stimulators of IL-6 synthesis are mitochondria-derived RNA species (mtRNA), which increase IL-6 synthesis through the RIG-I/MDA5 (retinoic acid-inducible gene-1/RIG-I-like receptor dsRNA helicase) cytosolic RNA recognition pathway [31]
Publication
Interleukin-6: An Under-Appreciated Inducer of Thermogenic Adipocyte Differentiation (2024) Ádám Radványi, et al. Int J Mol Sci. 2024 Mar;25(5). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | IL-6 | IL-6 | ncbigene_synonym | IL6 | 3569 |
| Homo sapiens | Primates | ATMs | ATM | ncbigene_symbol | ATM | 472 |
| Homo sapiens | Primates | PAF | PAF | ncbigene_synonym | PCLAF | 9768 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | UCP1* | UCP1 | ncbigene_symbol | UCP1 | 7350 |
| Homo sapiens | Primates | →RIG-I | RIG-I | ncbigene_synonym | RIGI | 23586 |
| Homo sapiens | Primates | MDA5 | MDA5 | ncbigene_synonym | IFIH1 | 64135 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| alkylglycerols | alkylglycerols | chebi:52575 | ||
| PAF | PAF | (2R)-2-acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate | chebi:44811 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|